Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

计划入组 52 人 · 首次发布于 2018 年 2 月 8 日

Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis

计划入组 150 人 · 首次发布于 2003 年 11 月 18 日

A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

计划入组 119 人 · 首次发布于 2024 年 3 月 7 日

Acetylcholine(Miochol)

C₇H₁₆NO₂

Zilucoplan(Zilbrysq)

C₁₇₂H₂₇₈N₂₄O₅₅

ATG-001

Cambridge Antibody Technology

New Zealand

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Study Reveals Link Between AChR Antibody Levels and Myasthenia Gravis Treatment Response

Teva and Samsung Bioepis Launch Epysqli, a 30% Discounted Biosimilar to Soliris for Rare Diseases

Zai Lab Secures Reimbursement Renewal for Three Key Therapies in China's 2025 National Drug List